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KEITH BORG. Involvement of Human Immunodeficiency Virus Type-l 
Splice Sites in the Cytoplasmic Accumulation of Viral RNA. (Under the 
direction of SALVATORE ARRIGO). 
The Human Immunodeficiency Virus Type 1 is a complex retrovirus, 
which produces a large number of proteins from a 10 Kb genome. The 
virus utilizes three overlapping open reading frames, a ribosomal 
frameshift event and three different classes of RNA (unspliced, partially 
spliced and fully spliced RNA) to perform this feat. To regulate the 
expression of these RNAs, HIV-l requires Rev, a viral trans regulatory 
protein. The fully spliced RNAs are not dependent upon Rev for their 
expression. The unspliced and partially spliced RNAs are dependent on 
Rev to produce proteins. Rev binds to the Rev Response Element (RRE) 
located in the Rev dependent RNAs. The sequences responsible for the 
lack of production of protein in the absence of Rev, have been termed Cis-
acting Repressor Sequences (CRS). Little is known about the mechanism 
or nature of CRS. It is believed that CRS serve to confer Rev dependence 
on the RNA and allow for the regulation of the RNA at a number of post-
transcriptional levels. It is our hypothesis that, since Rev regulates the 
production of the different classes of mRNA, splice sites are intimately 
involved in the regulation of these RNAs by Rev. To define the role of 
Human Immunodeficiency Virus type 1 splice sites in the cytoplasmic 
accumulation of viral RNAs, sequential deletion mutagenesis on an 
infectious proviral clone of HIV-l was performed. Deletion of the majority 
of intron sequences, containing previously identified CRS, did not 
attenuate CRS activity. Retention of either the first or second tat intron 
.. 
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preserved CRS activity. RNAs containing splice donor sequences, in the 
absence of known downstream splice acceptor sequences, retained CRS 
activity. These results indicate that the major HIV-l splice donors can 
function as CRS and function to negatively regulate the cytoplasmic 
accumulation of HIV-l RNAs in COS cells. In order to further analyze the 
role of a splice donor in Rev dependence, the wild type 5' splice donor of 
HIV-l was mutated in the context of other gag sequences. The unspliced 
RNA produced by the mutant construct still required Rev for the 
cytoplasmic accumulation of the RNA. Despite deletion of the wild type 5' 
splice donor, splicing still occurred, as measured by usage of the tat splice 
acceptor. A cryptic splice donor was identified by PCR and subsequent 
cloning of the spliced RNA. The cryptic site is 5/9 to the consensus 
sequence and located immediately downstream of the initiation codon 
(ATG) for Gag. Analysis of RNA containing the cryptic splice donor 
demonstrated that Rev is still required for the cytoplasmic accumulation 
of the unspliced RNA, while spliced RNA is Rev independent. These 
results indicate that a cryptic splice donor can be activated when the wild-
type splice donor is inactivated and that the cryptic splice donor retains 
Rev regulation. The findings also suggest the potential for cryptic splice 
sites to serve as CRS in determining the Rev-dependence of viral RNAs. 
These studies have investigated the critical role that splice sites can play 
in viral gene regulation and shown that splice sites, both wild-type and 





The complex gene regulation mechanisms of cells are utilized by 
viruses to regulate and facilitate programs of viral gene expression. To 
understand the coordinating mechanisms of viral gene regulation, it is 
crucial to understand the cellular processes involved in RNA processing in 
concert with gene expression. Eukaryotic processing of mRNA is a 
complex process that begins in the nucleus following transcription. An 
outline of the steps involved in RNA processing is depicted in Figure 1-1. 
Immediately following transcription, or even as it occurs, proteins called 
snRNPs (small nuclear ribonucleoproteins) associate with this primary 
transcript. snRNPs serve many functions during the processing of the 
transcript. The Ul, U2, U5 and U4/6 snRNPs are involved in formation of 
the catalytic spliceosome which serves to splice the pre-mRNA (see figure 
1.2) (Alberts et al., 1994) 
2 
Transcription of Primary Transcript 
• 
hnRNA Transcript Bind snRNPs 
Capping and Polyadenylation of RNA 
Splicing of mRNA 
Export of mRNA to Cytoplasm 
Translation 
Figure 1.1 RNA Expression Steps involved in RNA processing in the 
nucleus and subsequent export from the nucleus to the cytoplasm. 
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After transcription and snRNP binding, the RNA is covalently 
modified at the 5' and 3' ends of the primary transcript. The 5' end is 
capped with a 7-methyl Guanosine residue; which is important not only in 
protecting the RNA from degradation, but also in the initiation of 
translation. The 3' end of the primary transcript is polyadenylated by 
poly-A polymerase which adds a series of adenosine residues about 20bp 
downstream of the polyadenylation signal- AAUAAA (Alberts et at., 1994). 
This poly-A tail serves several functions in RNA processing including 
stabilization of the RNA and initiation of 60s ribosomal subunit binding 
for protein synthesis (Sachs and Wahle, 1993; Sachs, Bond, and Kornberg, 
1986; Sachs and Davis, 1989; Sachs and Deardorff, 1992). 
After initial processing the RNA is spliced via two trans-
esterification reactions to produce a spliced product. This process takes 
place when snRNPs bound to the RNA catalyze the cleavage and ligation 
of the two exons and removal of the intron (Moore, Query, and Sharp, 
1993). This multistep process is depicted in Figure 1.2. There are several 
critical sequences involved in the splicing pathway. At the 5' end of the 
intron there is a splice donor sequence which binds the Ul snRNP. At the 
3' end of the intron, the branch point sequence binds U2. There are two 
other important 3' sequences, the splice acceptor site and the 
polypyrimidine tract which are involved in the selection of the splice 
acceptor. UI and U2 then bind the U4/6 and U5 snRNPs which complex to 
form the spliceosome, the functional unit which removes introns from the 
primary transcript to produce a spliced RNA product (Adams, Rudner, and 
Rio, 1996; Moore, Query, and Sharp, 1993). This final product is then 
exported from the nucleus to the cytoplasm. 
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Figure 1.2 Splicing Pathway The process of splicing is shown with the 
various snRNPs binding to the primary RNA transcript followed by lariat 
formation, splice site cleavage and exon ligation the RNA to remove 
intronic sequences (Adapted from Moore by Justin Favaro) (Moore, Query, 
and Sharp, 1993). 
The normal process of eukaryotic RNA splicing is inherently 
different from that of the splicing of retroviral transcripts. This is because 
of the fact that retroviral primary transcripts are multiply and variably 
spliced to produce different viral mRNAs. (see Figure 1.3 and 1.5). The 
primary transcript itself also encodes structural proteins as well as 
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functioning as the genomic RNA for progeny virions and is exported 
unspliced into the cytoplasm of the cell. This is in contrast to unspliced 
cellular RNAs, which are not found in the cytoplasm. This incomplete 
splicing is an important step in the regulation because it provides the 
temporal switch between production of early viral regulatory proteins 
from completely spliced RNAs, to the production of structural proteins 
from unspliced and incompletely spliced RNAs (Arrigo and Beemon, 1988; 
Katz, 1990; O'Reilly, McNally, and Beemon, 1995). This critical 
mechanism of regulation is poorly understood. However, cis-acting 
mechanisms of splicing regulation have been examined. cis-acting 
elements have been described in retroviruses that downregulate splicing. 
Examples described include a negative regulator of splicing (nrs) 
identified in Rous sarcoma virus (Arrigo and Beemon, 1988). HIV-1 also 
has cis elements in env that downregulate splicing of the second intronic 
region (Amendt, Si, and Stoltzfus, 1995). These elements combine with the 
suboptimal consensus sequence of splice sites and decrease the efficiency 
of a normally efficient process. The decrease in efficiency of splicing is 
critical to the ability to regulate this process. 
After splicing, the cellular RNA is exported to the cytoplasm. Export 
of RNA is a regulated event that involves a series of steps that involve the 
binding of a number of cellular factors to facilitate transport across the 
nuclear membrane. The mechanisms of RNA export are currently a very 
active area of investigation as is the study of much of the regulation 
involving nuclear and cytoplasmic trafficking (Ullman, Powers, and 
Forbes, 1997). Elucidation of the mechanisms of transport and possible 
regulatory steps involved in the process will aid the understanding of the 
role of export in retroviral gene expression. 
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RNA metabolism is also regulated in the cytoplasm via interactions 
that regulate the stability and translational processing of the RNA. This 
is a brief description of the complex pathway of RNA processing. The 
importance of understanding the pathways of RNA processing can not be 
overemphasized. It is only through understanding the temporal 
processing of RNA that the possible regulation of those steps can be 
investigated. For now, a basic understanding of cellular RNA processing 
will allow. the exploration of the gene regulation and the life cycle of a 
complex retrovirus. 
The Human Immunodeficency Virus Type 1 (HIV-l) is a retrovirus 
which is the etiologic agent of the Acquired Immune Deficiency Syndrome 
(AIDS). (for review see Levy93) It is a member of the lentivirus genus of 
retroviruses. In a 10 kb genome, HIV-1 possesses at least 9 genes (Figure 
1.3). These genes include gag, pol, and env common to all retroviruses. 
HIV-l also has several regulatory genes- tat ,rev and net. Other accessory 
regulatory genes include vif, vpr, vpu and nef The gag gene encodes viral 
structural proteins. Translation of gag results in a polyprotein, which is 
subsequently cleaved by the viral protease into the component proteins-
matrix, capsid and nucleocapsid. Pol encodes the viral enzymes (reverse 
transcriptase, integrase, RNase H and protease). Env encodes the 
envelope proteins of the virus (gp120 and gp41). gp120 is inserted into the 
cell membrane and thereby incorporated into virions during budding. In 
infection gp120 functions as a ligand for the CD4 receptor which along 
with a chemokine receptor, facilitates the binding of the virion to the cell. 
The fusion of the viral envelope to the cell during infection is facilitated by 
the action of gp41. vir is involved in the infectivity of the virus. vpr plays 
a role in the pathogenesis of the virus during infection. vpu plays a role in 
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virus assembly. Nef, a regulatory protein produced from a fully spliced 
RNA, has two major functions in the viral life cycle; including the 
downregulation of CD4 receptors and involvement in viral pathogenesis 
during infection. 
ILTRI gag vif tat vpu ILTRI 
I r:::::::::J _0 env 
pro pol I I 
CJrev • c::::J Rev vpr nef dependence 
IiIim ... gag/pol + 
- IiIim ... env/vpu + ............ --.... --.... -- IiIim - .... ... tat + .... .... ........ -- - -.... ............ .... - ---- IiIim - .... - - ~ vpr + .... ........ -- -.... .... .... _- -.... -.... -.... .... -- IiIim • vif + - ........ .... - ,. ....... - ,. ............ ,. tat/rev - ,. -~ , ... .... ............ ,. .... .... ,. -- , / .... .... -- , / - .... ............ -- -~ , / / ~ nef .... -.... ........ - -- , ,/ / .... - , / ............ --- , / ........ --- '/ 
Figure 1.3 HIV-1 Genome and RNAs. The HIV-1 Genome and RNAs 
produced by the virus. The genome of HIV-1 is depicted along with the 
various RNAs produced through differential splicing of the full length 







HIV-1 expresses at least 17 proteins from a 9.6kb genome. In order 
to do this; the virus utilizes the mechanisms outlined previously, which 
include the production of three different classes of RNA. These are 
produced through various combinations of the major splice donors and 
splice acceptors. These RNAs and their protein products are depicted at 
the bottom of Figure 1.3 along with the splicing events required for their 
formation. 
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The gene expression of HIV-l is coordinated by the products of tat 
and rev. They share some common features. Both function in trans and 
are produced as early proteins produced from a fully spliced mRNA. 
Following translation both localize to the nucleus and bind target sites on 
RNA. After binding, tat and rev exert their effects on the RNA. Tat binds 
to the TAR element of the RNA and functions to increase transcription 
from the viral LTR. Tat serves primarily to increase the efficiency of 
elongation, but also may affect initiation of transcription (for review see 
Cullen95). It provides the "on" switch to begin the process of viral gene 
expression. Expression of HIV-1 genes is further controlled by Rev. Rev is 
a 19kd trans regulatory protein that is required for expression of viral 
structural proteins (Malim et al., 1988; Malim et al., 1989b; Sodroski et al., 
1986). The mechanism of Rev function is poorly understood. Many 
studies have found Rev to playa pivotal role at a number of points in viral 
gene expression. These points are the splicing, transport, stability and 
translation of mRNA. Rev binds to its recognition sequence, the Rev-
response element (RRE), located in env (see Figure 1.3). Rev can be divided 
into two functional regions (Figure 1.4). The N-terminal region binds to 
the RRE as well as containing a nuclear localization signal. This region 
consists of a series of arginine residues (Berger et al., 1991; Malim et al., 
1989a). Overlapping this domain is the multimerization region. Rev binds 
to the RNA as a monomer but subsequently multimerizes to achieve its 
effects (Olsen et al., 1990). The C-terminal region of the protein contains 
an effector domain consisting of a series of leucines (Berger et al., 1991; 
Malim et al., 1989a). Mutations in this region abolish function of the 
protein but produce trans dominant molecules. These trans dominants are 
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capable of binding to the RRE and inhibit the function of wild type Rev 
(Arrigo, Heaphy, and Haines, 1992; Garrett and Cullen, 1992). 
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N Multi RBD Multi Effector C 
Figure 1.4 Structural Domains of Rev. The functional regions of the Rev 
protein are indicated in the above diagram. The multimerization domain 
overlaps the RRE binding domain near the N-terminal of the protein. 
The RRE serves as a Rev binding site on the RNA. The RRE is a 234 
nucleotide stem-loop structure normally located in env (Hadzopoulou et al., 
1989; Malim et al., 1989b; Rosen et al., 1988). It is present in unspliced and 
partially spliced RNAs but is removed from the fully spliced RNAs (see 
Figure 1.3). The location of the RRE, within the RNA, is not important; as 
intronic sites appear to function as well as exonic sites for Rev function 
(Campbell, Borg, and Arrigo, 1996; Malim et al., 1989b). However, the 
effect of the RRE is orientation dependent (Hammarskjold et al., 1989). The 
structure of the RRE is a complex folded RNA that has specific structural 
components. One of these is the high affinity binding site for Rev that has 
been ascribed to the lIb region of the element. Other regions and sequence 
are important in multimerization and further binding of Rev to the RRE 
(I\jems et al., 1991; Mann et al., 1994). Following binding of Rev to the 
region it can then exert its effects on the fate of the RNA. 
Several theoretical mechanisms for Rev function have been 
proposed and tested. One is that Rev serves to enhance transport of the 
Rev-dependent RNAs, rescuing them from being trapped in the nucleus. 
This mechanism argues that Rev functions by binding to the RNA and 
then facilitating its transport from the nucleus to the cytoplasm. 
Experiments with Rev fused to BSA have shown functional export of the 
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proteins from the nuclei of Xenopus (Fischer et al., 1994). One piece of data 
absent in this mechanism was the identification of the cellular cofactors 
required for Rev to function in this manner. This factor has now been 
identified by several groups as a nucleoporin-like protein. Rev associates 
with this nucleoporin-like protein, which theoretically enables transport 
of the Rev bound RNA. This factor was identified using the yeast two-
hybrid system and contains similar motifs to nucleoporins, which are 
components of the nucleopore complex (Bogerd et al., 1995; Fritz, Zapp, and 
Green, 1995; Stutz, Neville, and Rosbash, 1995). Consequently, this 
protein may function as a cellular cofactor for Rev to facilitate export of 
bound RNAs. However, additional work is required in order to establish a 
clear relationship between Rev, the nucleoporin-like protein and the 
mRNA. 
Several lines of evidence suggest that Rev may directly affect 
splicing of HIV-1 RNAs in order to regulate production of the various 
species of HIV-1 RNA. An inhibition of splicing in vitro was demonstrated 
using a peptide containing the Rev RNA binding domain (Kjems, Frankel, 
and Sharp, 1991). This inhibition of splicing was not seen in vivo; 
therefore it is difficult to evaluate the relevance of this data. While 
certainly an attractive theory for Rev function, there is little evidence that 
Rev directly inhibits splicing to increase the production of unspliced and 
partially spliced RNA. It may be that the shift in production of RNAs is 
the result of changes in export, which indirectly change the levels of RNA 
or some combination of these effects. 
Several studies have shown effects of Rev on translation of RNA. 
They have demonstrated a translational effect, in that in the absence of 
Rev, RNAs can accumulate in the cytoplasm, but are not translated. 
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Several groups have shown these effects in lymphoid cells (Arrigo and 
Chen, 1991) and fibroblast cells (D'Agostino et al., 1992). The partially 
spliced messages accumulated in the cytoplasm, but were not translated. 
When examined by sucrose gradients, these untranslated RNAs were 
deficient in polysome formation. The fact that these RNAs could be 
translated in vitro strongly indicates a translational regulatory function 
for Rev. In the absence of Rev; Poly-A Binding Protein (PAB1) was not 
associated with the Rev-dependent messages. PABI binding has been 
shown to be critical for the association of the 60S ribosomal subunit and 
translation. At what stage Rev binding affects the association of PAB1 is 
unclear, but the failure to associate with PABI might be indicative of 
translational regulation of HIV-1 mRNAs by Rev. 
A possible cofactor for Rev, eIF-5A, may shed light on a mechanism 
of translational regulation. Initial studies reported the interaction 
between Rev and elF -5A. These studies were performed by crosslinking 
the proteins (Ruhl et al., 1993). Additional studies using transdominant 
eIF-5A proteins have also suggested an interaction with Rev (Katahira et 
al., 1995). This research is hampered by a lack of understanding of the 
function of eIF-5A. Without a clear understanding of the cellular role of 
eIF-5A, the importance of the data is difficult to estimate. While the level 
at which Rev functions and its various cellular cofactors are complex and 
poorly understood, the viral requirement for Rev remains absolute. 
The answer to the question of why Rev is required for the expression 
of the Rev-dependent RNAs may lie in a series of ill-defined sequences 
known as Cis-acting Repressor Sequences (CRS). These sequences, in the 
absence of Rev, have a negative effect on the RNA and prevent its 
cytoplasmic accumulation. CRS are RNA sequences that are defined 
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functionally. When present in RNA, eRS negatively regulate the 
expression of the RNA. The second criterion required for definition as a 
CRS is that Rev must be able to rescue the RNA from this negative 
regulation through binding to the RRE. Two major groups of sequences 
have been implicated as eRS 1) sequences in gag, pol and env (intronic 
CRS) and 2) splice sites (see Figure1.3 and 1.5). 
Several groups have worked to identify a series of eRS elements 
that are located in the gag, pol and env coding regions of the virus (Rosen 
et al., 1988). These eRS have several factors in common. They are large 
(200+bp), function in the sense orientation, have no obvious sequence 
homology and require a large number of mutations to delete their negative 
function. The eRS located in gag is perhaps one of the best studied of this 
type. It is located in the p17 region and required 28 point mutations in the 
270 bp element to inactivate. The inactivation of this eRS allowed for the 
discovery of another in the gag-pol region (Schwartz, Felber, and Pavlakis, 
1992a). Other groups have also noted eRS in pol which appear similar to 
the eRS described in gag. The eRS is 260bp in size, located 3' in pol and 
was defined by deletion mutagenesis (Cochrane et al., 1991). The nature of 
this element appears similar to that described for the gag CRS. The 
duplicative nature of these elements is certainly interesting. Why is there 
a need for so much redundancy in negatively regulating early expression 
of structural proteins? This question is largely unanswered. 
Multiple elements in env have been described as CRS. These 
elements appear similar to those described in gag (Nasioulas et al., 1994). 
After inactivation of an env eRS, other eRS were identified in env. This 
observation is similar to the identification of multiple elements in the gag-
coding region. Several groups have reported that the RRE functions as a 
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CRS (Brighty and Rosenberg, 1994; Nasioulas et al., 1994). This effect of 
the RRE is not seen in all systems, consequently the RRE may function as 
a CRS in only certain contexts. Studies of intronic CRS have not 
discovered a mechanism of function for the negative regulation of Rev 
dependent RNAs. Decreased stability, blocked export and translational 
inhibition have all been suggested as possible mechanisms for regulation 
of RNAs containing CRS. 
The second major class of identified CRS elements is splice sites. 
These have been identified in several different systems as negatively 
regulating RNA expression. The addition of HIV-1 splice donors and 
acceptors to heterologous constructs induces Rev dependence (Chang and 
Sharp, 1989). The splice donors of HIV-1 are fairly good matches to the 
consensus sequence identified for splice sites (Mount, 1982). The splice 
acceptors are notably poor in HIV-1 and several groups have reported that 
suboptimal splicing events are necessary for Rev-responsiveness of the 
RNA (O'Reilly, McNally, and Beemon, 1995). Other groups have noted 
CRS effects of splice donors when placed in the 3' UTR of papillomavirus 
constructs (Barksdale and Baker, 1995) and of the 5' splice donor of Equine 
Infectious Anemia Virus (Tan et al., 1996). The major 3' splice donor has 
been the subject of previous investigation and mediates the Rev 
dependence of env constructs. When the splice donor is mutated and an 
excisable intron was placed upstream, env expression became Rev 
independent (Hammarskjold et al., 1994). These studies indicate that 
splice donors can function as CRS and that the splicing event must be 
suboptimal in order to be regulated by Rev. The mechanisms of CRS 
function and Rev rescue of Rev dependent RNA are still largely unknown. 
Some groups have suggested instability, impaired nuclear export or 
15 
translational effects as the means by which RNAs are negatively 





vif tat ~u 






J ~ ________ I~J~JJ~T __ E~I~ ~ 
- ........ .... .... .... .... .... - .... .... ............ .... 
~ 
.... .... .... ............ .... .... 
.... .... ............ --.... -.... .... .... -........ --- ............ .... ............ .... .... ." .... ........ ." ." - .... .... .... ........ -........ ........ .... .... .... ........ ............ -- -........ 
............ -........ -.... -
------~E~--~~ 
---~B~-~ 
















.... --~ ,--~~ " / " / " / -~ " / /----~ - " ,,/ / ... " / " / " / " / .. 








The major splice sites of HIV-1 are depicted. Splice donors are shown as 
black triangles and splice acceptors as white triangles. These sites are 
used in combination to produce the viral RNAs. 
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CRS facilitate the regulation of HIV-l mRNA by Rev. However, the 
molecular mechanisms of this regulation remain undefined. In order to 
begin to explore the role of CRS function, it is critical to dissect apart the 
Rev-RRE axis of expression so those individual components can be 
examined for their function in HIV-l gene regulation. Consequently, it is 
critically important that transcription, splicing, export, stability and 
translation be considered as possible control points of CRS function. In 
examining the various steps of this axis of expression, we can begin to 
tease apart complex relationships between the components in order to 
better understand the gene expression of HIV-l. 
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Chapter 2 
Involvement of Human Immunodeficiency 
Type-1 Splice Sites in the Cytoplasmic Accumulation 
of Viral RNA 
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In trod uction 
Splice sites are important elements involved in the Rev-
responsiveness of HIV-1 mRNAs. This is true for several reasons. One is 
the variation in patterns of RNA produced in the presence and absence of 
Rev. Rev mediates the shift from the production of fully spliced RNA to the 
production of predominantly unspliced and partially spliced RNAs. The 
fact that splice donors can function as CRS also implicates splice site 
involvement in the Rev responsiveness of RNAs. By negatively regulating 
the RNA, splice donors serve as sequences (or at least some of the 
sequences) that establish the viral requirement for Rev. In order to 
explore this activity, we first wish to isolate splice sites to examine their 
role as regulatory elements involved in the cytoplasmic accumulation of 
HIV-1 mRNAs. A series of experiments with isolated splice sites will serve 
to characterize the function of these elements in HIV-1 gene expression. 
The constructs used to examine splice site function will contain deletions 
for known intronic CRS so that isolated splice donors and splice acceptors 
can be examined to determine their role in Rev responsiveness of HIV-1 
mRNA. 
The expression of HIV-1 structural proteins is regulated at the level of 
splicing, transport, stability, and translation by the Rev protein (Arrigo 
and Chen, 1991; Cochrane et al., 1991; DtAgostino et al., 1992; Feinberg et 
al., 1986; Felber et al., 1989; Hadzopoulou et al., 1989; Hammarskjold et al., 
1989; Lawrence et al., 1991; Malim et al., 1988; Schwartz, Felber, and 
Pavlakis, 1992a; Sodroski et al., 1986). The Rev protein binds to an RNA 
binding site termed the Rev-responsive element (RRE) present within the 
RNAs that it regulates (Hadzopoulou et al., 1989; Malim et al., 1989b; 
Rosen et al., 1988). This regulation may involve alteration of the cellular 
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pathway of the RNA (Fischer et al., 1995). The Rev-dependent RNAs 
require Rev for protein expression and therefore must contain negative 
sequences, the effect of which is overcome by the Rev protein (for review 
see Dayton 1996). The Rev-independent tat, rev, and nef genes presumably 
do not contain these sequences. These negative sequences have been 
termed cis-acting repressor sequences, CRS, and have been characterized 
in a variety of experimental systems. Splice sites have been implicated in 
Rev regulation by several groups. Introduction of sequences containing 
the HIV-1 tat 31 splice donor or splice acceptor sequences (i.e., those splice 
sites that join the Tat coding exons) into a construct containing a B-globin 
intron conferred Rev-responsiveness to the construct (Chang and Sharp, 
1989). Rev-responsiveness could also be conferred by mutation of the B-
globin splice site consensus sequence within this construct. The CRS 
potential of splice donor sequences has been demonstrated by the Rev-
responsiveness of papillomavirus constructs containing a splice donor in 
the 31 untranslated region (Barksdale and Baker, 1995). The major 51 
splice donor of equine infectious anemia virus functions as a CRS within 
EIAV Gag-producing constructs, although it functions in a location-
dependent manner (Tan et al., 1996). Within HIV-1 Env-expressing 
constructs, splice sites and V1 interaction have been shown to be 
important for the regulation of Env expression by Rev (Lu et al., 1990). 
Furthermore, the expression of Env could be made Rev-independent by 
placing a complete intron upstream of env and removing known splice 
donor sequences (Hammarskjold et al., 1994). 
Other sequences within HIV-1, distinct from splice sites, have also 
been shown to exhibit CRS activity. The fusion of various fragments of the 
gag, pol, and env genes to a CAT reporter construct resulted in Rev-
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responsiveness (Cochrane et al., 1991; Rosen et al., 1988). The CRS within 
pol elicited an orientation-dependent 30-fold negative effect on CAT 
activity that could be rescued by Rev and the RRE. This CRS is located 
within HIV-l sequences that are not known to contain any splice sites. 
The effect appeared to be at the mRNA utilization level in that the 
subcellular distribution of RNA was not substantially affected. Fusion of 
regions of both gag and pol to reporter constructs also demonstrated at 
least two orientation-dependent eRS that functioned 
posttranscriptionally (Maldarelli, Martin, and Strebel, 1991). These 
sequences do not contain known splice sites and were not substantially 
affected by the addition of splice sites to the constructs. Fusions of gag to a 
tat-expression vector were used to analyze eRS activity within gag 
(Schwartz, Felber, and Pavlakis, 1992a). A less than 300 base pair 
fragment of gag was capable of exerting an effect on the total RNA 
production, which was attributed to differences in RNA stability. 
Mutational inactivation of this CRS required 28 point mutations, 
demonstrating the complex nature of this eRS (Schwartz et al., 1992). In 
the absence of known splice sites, env expression was shown to be Rev-
dependent in mammalian cells using Env expression vectors (Nasioulas et 
al., 1994). Localization of eRS within env identified many regions capable 
of exerting modest negative activity, which together exerted activity that 
is more dramatic. Deletion of the RRE led to Rev-independent expression 
of Env from subgenomic env constructs, indicating that a eRS may 
overlap RRE sequences (Brighty and Rosenberg, 1994; Churchill et al., 
1996). The complexity of the interaction between the gag eRS and splicing 
was recently demonstrated (Mikaelian et al., 1996). The gag eRS in 
conjunction with the RRE was capable of conferring Rev-responsiveness 
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on a B-globin construct. Mutations in splice sites rendered these 
constructs Rev-independent. Therefore, it appears that CRS may function 
at a variety of levels to decrease the expression of RNAs containing these 
elements. 
In this chapter, we investigated the involvement of HIV-l splice 
sites in Rev regulation through sequential mutagenesis of an infectious 
proviral clone. In order to avoid the complexities of analyzing multiple 
types of CRS, the majority of intronic sequences were deleted, retaining 
the splice sites necessary for the production of the multiply spliced RNAs. 
Analysis of the ratio of cytoplasmic to nuclear HIV-l RNAs, in the 
presence or absence of Rev or the RRE, using these constructs served as 
an indicator of CRS activity. 
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Materials and Methods 
Plasmid Constructions 
The BI construct was constructed from pYKJRCSFIEBV- (Arrigo 
and Chen, 1991) using DR mutagenesis (Gatlin et al., 1995). gag, pol, vit 
and part of vpr were deleted (nt790-5710), leaving the major splice donor 
and Gag methionine intact. env and vpu were removed by deleting from 
just downstream of the 3' splice donor for tat, rev, and net to just upstream 
of the most 3' splice acceptor (nt6145-8307). The BI construct retains the 
splice sites for the generation of tat, and is deleted for the majority of tat 
intronic sequences. The BIR construct was generated by insertion of an 
RRE-containing SalI fragment into the XhoI site within the net sequences 
of the BI construct (Campbell, Borg, and Arrigo, 1996). FI and FIR 
constructs were generated using DR mutagenesis. The second tat/rev 
intron was deleted in frame from the BI and BIR constructs using the 
following oligonucleotide primers: 5'-
TGCTTTGGTAGAGAAACTTGATGAGTCTGAC-3' and 5'-
ACCCTCCTCCCAGCAACGAG-3'. This deletion creates an in-frame 
fusion of the two tat coding exons. SI and SIR constructs were generated 
using DR mutagenesis. The first tat intron was deleted from BI and BIR 
constructs using the following oligonucleotide primers: 5'-
CAGTCGCCGCCCCTCGCCTC-3' and 5'_ 
AATTGGGTGTCGACATAGCAGAATAGGC-3' . 
The SD2R construct was generated by restriction digestion of the SIR 
construct with BamHI and religation. The SDI construct was generated 
using PCR and contains sequences from nt153-793, and nt9036-9736 from 
pYKJRCSF, including the sequences encompassing the major 5' HIV-l 
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splice donor. These sequences were cloned into pGem2 (Promega). The 
SD1R construct was generated by insertion of the RRE-containing SpeI 
fragment (Campbell, Borg, and Arrigo, 1996) into the SD1 construct. The 
NI construct was generated by the cloning of a PCR fragment into the SD1 
construct. A 160 bp fragment was amplified using the BI construct as a 
template and the oligonucleotide primers: 5'-
ACAACCATGGAGGCTAGCTAGGGAACCCACTG-3' and 5'-
AACAGAATTCTCGCTTTCCGGTCCCTGTTC-3'. PCR conditions were as 
previously described (Arrigo, Heaphy, and Haines, 1992). The PCR 
product and the SD1 construct were digested with NcoI and EcoRI. The 
PCR product was inserted into the SD1 construct to generate NI using 
standard molecular techniques. The NI construct contains a deletion of 
almost all sequences between the splice donor and the polyadenylation 
signal, retaining 78 base pairs between these two elements. L1NI was 
generated from the NI construct using DR mutagenesis and the following 
oligonucleotide primers: L1SD1, 5'_ 
AGAACCGCGGACGCCGAAATTTTGACTAGCGGAGGC-3' and L1SD1A, 
5'-ACTACCGCGGGTCGCCGCCCCTCGCCTCTTGC-3'. This results in 
the deletion of the consensus splice donor site, TGGTGAGT, from the NI 
construct and the insertion of the sequence CCGCGG. 
Cell Culture and Transfection 
COS cells were maintained in Iscove's medium supplemented with 
10% fetal calf serum. Transfections were performed as described 
previously (Arrigo et al., 1989). A total of 50 Jlg of plasmid DNA was 
electroporated for each sample. Cotransfections were performed with the 
indicated construct without or without the addition of pSVtat and/or 
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pCMV Rev (Lewis et ai., 1990). A filler construct (pcDNA3, Invitrogen) 
was used to normalize the total amount of DNA to 50Jlg. A confluent 
T175cm2 flask of cells was used for approximately six transfections. RNA 
was harvested approximately 40 hours post-electroporation. 
RNA fractionation and analysis 
Cells were fractionated as previously described (Favaro and Arrigo, 
1997). Isolation of RNA and RT-PCR was performed as previously 
described (Arrigo and Chen, 1991; Arrigo et al., 1989; Arrigo et al., 1990). 
RT-PCR was performed for 20 cycles of amplification for all RNAs except 
that of the total RNA produced by NI and ilNI which was amplified for 15 
cycles. Most of the oligonucleotide primers used for detection have been 
previously described (Arrigo and Chen, 1991; Arrigo et al., 1989; Arrigo et 
al., 1990). The unspliced RNAs produced by the BIIBIR, FIIFIR, SDI/SDIR, 
and NIIilNI constructs was detected with the LA8/Gag-Nco oligonucleotide 
primers. The unspliced RNAs produced by the SIISIR and SD2/SD2R 
constructs were detected with the LA45/AA821 oligonucleotide primers. 
The spliced RNAs produced by the BIIBIR and SIISIR constructs were 
detected with the LA45ILA41 oligonucleotide primers. The spliced RNAs 
produced by the FIIFIR constructs were detected with the LA8ILA23 
oligonucleotide primers. Oligonucleotide primers LA23 (5'-
GCCTATTCTGCTATGTCGACACCC-3'; nt5815-5792) and Gag-Nco (5'-
CGCACCCATGGCTCTCCTTCTAG-3'; nt797-775) are antisense primers 
homologous to sequences downstream of the most 5' tat splice acceptor and 
major 5' splice donor, respectively. Total RNA produced by the SDIR, 
SD2R, and NIILlNI constructs was detected with an oligonucleotide pair 
located upstream of the major 5' splice donor: LDR1 (5'_ 
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GAACAGGGACCGGAAAGCG-3'; nt644-662) and a-LDRI (5'-
GC GC GCTTCAGCAAGC CGAG-3 '; nt716-697). 
Quantitation of the ratio of cytoplasmic to nuclear RNA was 
performed by scanning autoradiographs with a Lacie DTP Silverscan III 
scanner. Individual bands were quantitated with NIH Image 1.59. 
Analysis was performed on a Macintosh 7100/80 computer using the 
public domain NIH Image program (developed at the U.S. National 
Institutes of Health and available from the Internet by anonymous FTP 
from zippy.nimh.nih.gov or on floppy disk from the National Technical 
Information Service, Springfield, Virginia, part number PB95-
500195GEI). The cytoplasmic fractions (Cyto 1 and Cyto 2) were added 
together and compared to the nuclear fraction to determine the ratio of 
cytoplasmic to nuclear RNA. The level of nuclear RNA was arbitrarily set 
to a level of 1. 
Results 
Deletion of the majority of intronic sequences from HIV·l does 
not eliminate eRS activity. 
CRS activity has been attributed to intronic sequences within gag, 
pol and env. Starting with an infectious clone of HIV-l, the majority of 
intronic sequences were deleted. These deletions remove most of the 
sequences known to contain CRS activity. The resultant construct, BI, 
retains minimal amounts of both HIV-l tat introns (Fig. 2.1). The BI 
construct retains 145 nucleotides of 5' and 150 nucleotides of 3' intronic 
sequences. The RNA produced by the BI construct should retain the 
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ability to splice both of these minimal introns and should produce all three 
classes of HIV-1 RNA (unspliced, partially spliced and fully spliced). In 
addition, this construct should be capable of producing the Tat and Rev 
regulatory proteins. This construct did not contain the RRE, which has 
been shown to exhibit CRS activity in some experimental systems 
(Brighty and Rosenberg, 1994; Churchill et al., 1996). The RRE was 
inserted into the net gene of this construct to generate the construct BIR 
(Fig. 1). The presence of the RRE at this site has been previously shown to 
function in a similar manner to the normal location of the RRE (Campbell, 
Borg, and Arrigo, 1996). Since the BIR construct both produces Rev and 
contains the RRE, comparison of the distributions of RNAs produced by 
this construct with the distributions of RNAs produced by the BI 
construct should provide a good indication of the presence of CRS activity 
in the BI construct. The BI and BIR constructs were analyzed by 
transient transfection into COS cells. The cells were separated into three 
subcellular fractions (Favaro and Arrigo, 1997). RNA was isolated and 
analyzed using a quantitative RT-PCR procedure (Arrigo et al., 1989). 
The results are shown in figure 2.2. The autoradiographs were 
quantitated to determine the ratio of cytoplasmic to nuclear RNA (C:N). A 
ratio of 1:1 indicates that 50% of the RNA was found in the cytoplasmic 
fractions and 50% was found in the nuclear fraction. In the absence of the 
RRE, the unspliced RNA produced by the BI construct had a 
predominantly nuclear distribution, as evidenced by a C:N ratio of 0.2:1. 
In the presence of the RRE, the unspliced RNA produced by the BIR 
construct had a predominantly cytoplasmic distribution, as evidenced by a 
C:N ratio of 4.5:1. The fully spliced RNA accumulated predominantly in 
the cytoplasm, regardless of the presence or absence of the RRE. The 
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ratios of cytoplasmic to nuclear spliced RNA produced by the BI and BIR 
constructs were 20:1 and 16:1, respectively. The difference in the C:N ratio 
of unspliced RNA produced by the BI and BIR constructs indicated that 
the unspliced RNA produced by the BI construct retained substantial 
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Figure 2.1. Constructs used to localize CRS activity in HIV-1. Schematic 
diagram of HIV-l genome, HIV-1 RNAs, and constructs generated. Splice 
donors are represented as filled triangles and splice acceptors are 
represented as open triangles. Deletions are represented as open boxes. 
The filled circle represents the mutated splice donor site. The location of 
the RRE in the appropriate constructs is shown. Oligonucleotide primers 
used for detection of various RNAs are depicted as arrows above the RNAs. 
LDR and aLDR are homologous to sequences in the RNA leader sequence 
present in all RNAs. LA8 is just upstream and Gag-Nco is just 
downstream of the major 5' splice donor. AA821 is just downstream of the 
env splice acceptor. LA23 is just downstream of the 5' tat splice acceptor. 
LA45 is just upstream of the major 3' splice donor and LA41 is just 
downstream of the 3' tat / rev splice acceptor. 
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Figure 2.2. Effect of deletion of the majority of intronic sequences on CRS 
activity. Results of RT-PCR analysis, using fractionated RNAs (Cyto 1, 
Cyto 2 and Nuclear) from COS cells transfected with 50llg of the indicated 
constructs. Cyt01 and Cyto 2 fractions were generated using a buffer 
containing 0.05% NP40 and 0.65% NP40, respectively. The remaining 
pellet was designated the Nuclear fraction. Detection of unspliced and 
fully spliced RNAs is shown. Threefold dilutions of RNA from transfected 
cells were assayed to demonstrate the quantitative nature of this 
procedure. 
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Presence of a minimal intron maintains CRS activity 
The unspliced RNA produced by the BI construct contained eRS 
activity, although this constr~ct was deleted for the majority of HIV-l 
intronic sequences. Therefore, we wished to independently examine 
constructs containing each of the minimal tat introns for the retention of 
CRS activity within the unspliced RNA. To independently examine the 
first tat intron, a construct which contained sequences encoding the first 
minimal tat intron was generated (FI; Fig. 2.1). This construct was 
generated by precisely deleting sequences encoding the second tat intron 
from the BI construct, conserving tat and rev reading frames. The FI 
construct should produce an unspliced RNA and a spliced RNA encoding 
Tat and Rev proteins. The FIR construct was generated through insertion 
of an RRE into the nef gene of the FI construct (Fig. 2.1). Both FI and FIR 
constructs were transfected into COS cells and assessed by RT-PCR 
analysis of fractionated RNAs (Fig. 2.3). In the absence of the RRE, the 
unspliced RNA produced by the FI construct had a predominantly nuclear 
distribution, as evidenced by a C:N ratio of 0.4: 1. In the presence of the 
RRE, the unspliced RNA produced by the FIR construct had a 
predominantly cytoplasmic distribution, as evidenced by a C:N ratio of 
2.0:1. The fully spliced RNA accumulated predominantly in the cytoplasm, 
regardless of the presence or absence of the RRE. The ratios of cytoplasmic 
to nuclear spliced RNA produced by the FI and FIR constructs were 4.4: 1 
and 3.8:1, respectively. The difference in the C:N ratio of unspliced RNA 
produced by the FI and FIR constructs indicated that the 
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Figure 2.3. Effect of the first minimal tat intron on CRS activity. Results 
of RT-PCR analysis, using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear, 
as in Fig. 2) from COS cells transfected with 50J..1g of the indicated 
constructs. Detection of unspliced and fully spliced RNAs is shown. 
Threefold dilutions of RNA from transfected cells were assayed to 
demonstrate the quantitative nature of this procedure. 
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unspliced RNA produced by the FI construct retained substantial levels of 
CRS activity. 
To independently examine the second tat intron for CRS activity, a 
construct containing sequences encoding the second minimal tat intron 
was generated (SI; Fig. 2.1). This construct was generated by deletion of 
sequences encoding the first tat intron. The SI construct should produce 
an unspliced RNA encoding the Tat protein and a spliced RNA encoding 
Tat and Rev proteins. The SIR construct was generated through insertion 
of an RRE into the nef gene of the SI construct (figure 2.1). Both the SI 
and SIR constructs were transfected into COS cells and assessed for CRS 
activity by RT-PCR analysis of fractionated RNAs. The results are shown 
in figure 2.4. In the absence of the RRE, the unspliced RNA produced by 
the SI construct had a predominantly nuclear distribution, as evidenced 
by a C:N ratio of 0.8:1. In the presence of the RRE, the unspliced RNA 
produced by the SIR construct had a predominantly cytoplasmic 
distribution, as evidenced by a C:N ratio of 2.4:1. The fully spliced RNA 
accumulated predominantly in the cytoplasm, regardless of the presence 
or absence of the RRE. The ratios of cytoplasmic to nuclear spliced RNA 
produced by the SI and SIR constructs were 20:1 and 16:1, respectively. 
The difference in the C:N ratio of unspliced RNA produced by the SI and 
SIR constructs indicated that the unspliced RNA produced by the SI 
construct retained substantial levels of CRS activity. 
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Figure 2.4. Effect of the second minimal tat intron on CRS activity. 
Results of RT-PCR analysis, using fractionated RNAs (Cyto 1, Cyto 2 and 
Nuclear, as in Fig. 2) from COS cells transfected with 50Jlg of the indicated 
constructs. Detection of unspliced and fully spliced RNAs is shown. 
Threefold dilutions of RNA from transfected cells were assayed to 
demonstrate the quantitative nature of this procedure. 
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Deletion of utilized splice acceptors does not eliminate CRS 
activity 
Results had indicated that CRS activity was exhibited by RNAs 
containing either minimal tat intron. To further define the sequences 
responsible for the CRS activity within RNAs produced by the FI 
construct, the SD1 construct was generated. This construct retains the 
sequences encoding the 5' splice donor; however, sequences encoding all 
known splice acceptor sites have been removed (Fig. 2.1). The SD1 
construct should produce only an unspliced RNA; however splicing was 
detected in the RNA produced by this construct (see below). The SD1R 
construct was generated through insertion of an RRE into the SD1 
construct (Fig. 2.1). SD1 and SD1R constructs were transfected into COS 
cells and assessed by RT-PCR analysis of fractionated RNAs using 
oligonucleotide primers that flanked the splice donor sequences to detect 
unspliced RNA. As these constructs do not produce Tat, all transfections 
included a Tat-producing plasmid. These constructs also do not produce 
Rev; therefore, transfections were performed in the presence or absence of 
a Rev-producing plasmid. The results are shown in figure 2.5, upper 
panel. The unspliced RNA produced by the SD1 construct, in the absence 
of Rev, was found predominantly in the nuclear fraction as evidenced by a 
C:N ratio of 0.6:1. The C:N ratio of unspliced RNA produced by the SDI 
construct was not affected by the addition of Rev, as evidenced by a C:N 
ratio of 0.4:1. In the absence of Rev, the SD1R construct exhibited a 
similar RNA profile to that of the SD1 construct, as evidenced by a C:N 
ratio of 0.6:1. However, in the presence of Rev, the ratio of cytoplasmic to 
nuclear unspliced RNA produced by the SDIR construct was increased to 
a ratio of 5.5:1. These results indicated that the SD1R construct, 
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containing the major HIV-1 5' splice donor, retained CRS activity within 
the unspliced RNA. 
Although no known splice acceptor sequences were present within 
the SD1R construct, it was still possible that a cryptic spice acceptor 
might' have been utilized in conjunction with the 5' splice donor. To 
determine whether the splice donor was utilized in the RNA produced by 
the SD1R construct, we further examined the RNA produced by this 
construct using oligonucleotide primers specific for sequences upstream of 
the splice donor to detect total RNA, both spliced and unspliced (Fig. 2.5, 
lower panel). In contrast to results using primers that detected only 
unspliced RNA, the use of this set of primers indicated that Rev had little 
effect on the ratio of cytoplasmic to nuclear RNA produced by the SDIR 
construct. In fact, the bulk of the total RNA was found in the cytoplasmic 
fractions regardless of the presence or absence of Rev as evidenced by C:N 
ratios of 3.6:1 in the presence of Rev and 6.6:1 in the absence of Rev. This 
difference in C:N ratio was not seen in other experiments. These results 
indicated that the splice donor site within the RNA produced by the SDIR 
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Figure 2.5. Effect of deletion of known splice acceptors and retention of 
the major 5' splice donor on CRS activity. Results of RT-PCR analysis, 
using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear, as in Fig. 2) from 
COS cells transfected with 30J.1g of the indicated constructs. Detection of 
unspliced (upper panel) and total (lower panel) RNAs is shown. Threefold 
dilutions of RNA from transfected cells were assayed to demonstrate the 
quantitative nature of this procedure. All transfections also contained 10 
J.1g of a Tat-producing construct. The presence or absence of 10J.1g of a Rev-
prod ucing construct is indicated( + or-). 
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To better elucidate the CRS activity present within the unspliced 
RNA produced by the SI construct, the SD2R construct was generated. 
This construct retains sequences encoding the major 3' HIV-1 splice donor. 
Although the sequences encoding the env / nef splice acceptor are retained, 
they are positioned upstream of the 3' splice donor. The SD2R construct 
should produce only an unspliced RNA encoding Tat; however splicing was 
detected in the RNA produced by this construct (see below). The SD2R 
construct was transfected into COS cells and assessed by RT-PCR 
analysis of fractionated RNAs using oligonucleotide primers that flanked 
the splice donor sequences to detect unspliced RNA. As this construct does 
not produce Rev, transfections were performed in the presence or absence 
of a Rev-producing plasmid. The results are shown in figure 2.6. In the 
absence of Rev, the unspliced RNA produced by the SD2R construct had a 
C:N ratio of 0.5:1. However, in the presence of the Rev, the ratio of 
cytoplasmic to nuclear unspliced RNA was 2.8:1. These results indicated 
that the unspliced RNA produced by the SD2R construct retained CRS 
activity. 
The RNA produced by the SD2R construct was further analyzed 
using oligonucleotides directed against sequences upstream of the splice 
donor to detect total RNA produced by the construct (Fig. 2.6). In contrast 
to results using primers that detected only unspliced RNA, the use of these 
primers indicated that Rev had little effect on the distribution of RNA 
produced by the SD2R construct as evidenced by C:N ratios of 3.5:1 in the 
absence of Rev and 4.4:1 in the absence of Rev. These results indicated 
that the splice donor site within the SD2R construct was utilized in 
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Figure 2.6. Effect of deletion of known downstream splice acceptors and 
retention of the major 3 r splice donor on CRS activity. Results of RT-PCR 
analysis, using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear, as in Fig. 
2) from COS cells transfected with 25Jlg of the SD2R construct. Detection 
of unspliced and total RNAs is shown. Threefold dilutions of RNA from 
transfected cells were assayed to demonstrate the quantitative nature of 
this procedure. The presence or absence of 25Jlg of a Rev-producing 
construct is indicated (+ or - ). 
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An isolated splice donor functions as a CRS. 
Results obtained using the SD1R and SD2R constructs indicated 
that, in both cases, the splice donors were being utilized in conjunction 
with cryptic splice acceptors. The NI construct was generated through 
deletion of the bulk of sequences between the splice donor and the 
polyadenylation signal, leaving only 78 base pairs between these elements. 
Due to the lack of sequences downstream of the splice donor, we 
anticipated that the RNA produced by the NI construct would be 
extremely limited in its utilization of the major 5' splice donor. To 
elucidate the role of the major 5' splice donor in the manifestation of CRS 
activity, site-directed mutagenesis of this site within the NI construct was 
performed. The consensus splice donor sequence within the NI construct 
was mutated to generate the NI construct (Fig.2.1). NI and ~NI constructs 
were transfected into COS cells in duplicate. Since these constructs do not 
produce Tat, all transfections included a Tat-producing plasmid. 
Fractionated RNAs were assessed by RT-PCR analysis using 
oligonucleotide primers that flanked the splice donor sequences. The 
results are shown in figure 2.7. The unspliced RNA produced by the NI 
construct was detected predominantly in the nuclear fraction as evidenced 
by a C:N ratio of 0.2:1-0.3:1. Mutation of the splice donor site (ilNI) 
resulted in an increase in the ratio of cytoplasmic to nuclear unspliced 
RNA as evidenced by a C:N ratio of 1.0:1-1.3:1. These results indicated 
that the 5' splice donor was functioning as a CRS within the unspliced 
RNA produced by the NI construct. To determine the extent to which the 
5' splice donor was utilized, the RNA produced by the NI and ilNI 
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constructs was further analyzed using oligonucleotides directed against 
sequences upstream of the splice donor to detect total RNA, both spliced 
and unspliced (Fig. 2.7). The ratio of cytoplasmic to nuclear total RNA 
produced by the NI construct was altered in that the C:N ratio was 
increased to 1.0:1-1.5:1. These results indicated that splicing was not 
completely eliminated within the RNA produced by the NI construct. 
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Figure 2.7. The major 51 HIV-1 splice donor functions as a CRS. Results 
of RT-PCR analysis, using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear, 
as in Fig. 2) from COS cells transfected with 40J.!g of the indicated 
constructs in duplicate. Detection of unspliced and total RNAs is shown. 
Threefold dilutions of RNA from transfected cells were assayed to 
demonstrate the quantitative nature of this procedure. All transfections 
also contained 10 J.!g of a Tat-producing construct. 
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Discussion 
eRS have been identified throughout the intronic sequences of HIV-1, in 
gag, pol, and env (Brighty and Rosenberg, 1994; Cochrane et al., 1991; 
Maldarelli, Martin, and Strebel, 1991; Nasioulas et al., 1994; Rosen et al., 
1988; Schwartz, Felber, and Pavlakis, 1992a). In addition, splice sites have 
been implicated in HIV-l Rev function (Barksdale and Baker, 1995; Chang 
and Sharp, 1989; Hammarskjold et al., 1994; Mikaelian et al., 1996; Tan et 
al., 1996). In this report, the CRS activity of HIV-l splice sites was 
investigated through sequential mutagenesis of a proviral clone. In the 
absence of the majority of HIV-1 intronic sequences, it was observed that 
Rev-responsiveness was maintained. It is possible that an important 
component of CRS activity was lost through deletion of these intronic 
sequences. The intronic sequences may still have a significant impact on 
eRS activity within the virus. 
Unspliced RNAs containing either the first or second tat intron 
exhibited CRS activity. Removal of known splice acceptors did not 
eliminate the CRS activity present within the RNAs. These RNAs 
contained either the major 5' or 3' HIV-l splice donor site. In the absence 
of any known downstream splice acceptors, these splice donors were still 
efficiently utilized, in conjunction with cryptic splice acceptors. Deletion 
of nearly all sequences between the major 5' HIV-1 splice donor and the 
polyadenylation site appeared to reduce, but did not eliminate, the 
utilization of the 5' major splice donor. Although deletion of these 
sequences did not relieve the eRS activity within the unspliced RNA, 
mutation of the splice donor did relieve eRS activity. Therefore, the major 
HIV-l 5' splice donor could function as a CRS, even in the absence of 
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efficient splicing. These results clearly demonstrated that the HIV-1 
splice donor sites are intimately involved in the regulation of the 
cytoplasmic accumulation of viral RNA. 
The mutation of the splice donor site within i1NI also led to an 
apparent decrease in the total level of RNA. This reduction may be due to 
a decrease in stability of the RNA caused by the removal of the splice 
donor. A similar effect on total RNA levels was previously observed when 
the major 3' HIV-1 splice donor was mutated within a subgenomic env 
construct (Lu et al., 1990); although the effect seen in the previous report 
was more severe and led to an almost complete inability to detect any RNA 
produced from the construct. 
Results from other groups support the idea that an isolated splice 
donor might function as a CRS. Naturally occurring inhibitory 5' splice 
sites within the 3' untranslated region of papillomaviruses were shown to 
function as CRS in that Rev can counteract their effect (Barksdale and 
Baker, 1995). The major 5' splice donor of equine infectious anemia virus 
was demonstrated to function as a CRS (Tan et al., 1996). A B-globin splice 
donor was shown to be capable of functioning as a CRS (Chang and Sharp, 
1989; Hammarskjold et al., 1994; Mikaelian et al., 1996). The HIV-1 tev 
splice donor, located within the HIV-1 env gene, also appears to function as 
a CRS (Hammarskjold et al., 1994). The results presented in this chapter 
indicate that authentic HIV-1 splice donors function as CRS to prevent the 
cytoplasmic accumulation of viral RNAs. The identification of utilized 
HIV-1 splice donor sites as eRS leaves open the possibility that cryptic 
HIV-1 splice donor sites might also function as CRS when expressed 
within the appropriate context. 
46 
It seems apparent that the control of HIV-1 RNA production 
involves a variety of regulatory activities. Splicing serves to downregulate 
the level of cytoplasmic unspliced and partially spliced RNAs. The splice 
donors themselves also serve to downregulate the cytoplasmic 
accumulation of those RNAs in which they are present. The intronic CRS 
may serve to retain RNA in the nucleus, decrease RNA stability, or 
decrease RNA cytoplasmic utilization (Brighty and Rosenberg, 1994; 
Cochrane et al., 1991; Maldarelli, Martin, and Strebel, 1991; Nasioulas et 
al., 1994; Rosen et al., 1988; Schwartz, Felber, and Pavlakis, 1992a). The 
combination of each of these regulatory activities may synergize within 
the virus to prevent viral structural protein production. Rev may serve to 
overcome all of these levels of negative regulation and permit viral 
structural protein production. 
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Chapter 3 
Activation of a Rev-Dependent Cryptic Splice Donor in Human 
Immunodeficiency Virus Type-1 
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In trod uction 
By examining isolated sequences, such as splice sites or intronic 
CRS, it is possible to ascribe functions to these elements. However, unless 
they are examined together, it is not possible to accurately predict the 
interplay of splice sites and intronic CRS that are responsible for the Rev 
regulation of viral expression. Much of the work on eRS and Rev 
regulation in HIV-1 has been done in disparate systems where relevance of 
the results becomes an important criticism. Therefore, it is important to 
establish the biological relevance of the isolated phenotype in the context 
of a more complete virus. The function of splice sites on Rev-
responsiveness in the context of a construct that contains intronic eRS 
will be examined. It is hoped that this analysis, while more complex, will 
provide important insight into the relationship between splice sites and 
intronic eRS and outline possible mechanisms of eRS function. 
The HIV-1 protein Rev regulates the expression of viral structural 
proteins at the level of splicing, transport, stability, and translation 
(Arrigo and Chen, 1991; Cochrane et al., 1991; D'Agostino et al., 1992; 
Feinberg et al., 1986; Felber et al., 1989; Hadzopoulou et al., 1989; 
Hammarskjold et at., 1989; Lawrence et al., 1991; Malim et at., 1988; 
Schwartz, Felber, and Pavlakis, 1992b; Sodroski et al., 1986) . Rev performs 
this activity by binding to an RNA binding site termed the Rev-responsive 
element (RRE) present within the RNAs that it regulates (Hadzopoulou et 
al., 1989; Malim et al., 1989b; Rosen et al., 1988). Rev may function by 
alteration of the cellular pathway of the RNA (Fischer et al., 1995). Since 
Rev is required for protein expression, the Rev dependent RNAs must 
contain negative sequences, which Rev overcomes for expression (for 
49 
review see Dayton 1996) (Dayton, 1996). These sequences should not be 
present in the Rev-independent tat, rev, and nef genes. These negative 
sequences have been termed cis-acting repressor sequences, CRS, and 
have been characterized in a variety of experimental systems. Splice sites 
have been identified in Rev regulation by several groups (Barksdale and 
Baker, 1995; Chang and Sharp, 1989; Hammarskjold et al., 1994; 
Mikaelian et al., 1996; Tan et al., 1996). In addition, the isolated major 5' 
splice donor of HIV-1 functions as a CRS (Borg, Favaro, and Arrigo, 1997). 
Introduction of sequences containing the HIV-1 tat 3' splice donor or splice 
acceptor sequences (i.e., those splice sites that join the Tat coding exons) 
into a construct containing a B-globin intron conferred Rev-
responsiveness to the construct (Chang and Sharp, 1989). Rev-
responsiveness could also be conferred by mutation of the B-globin splice 
site consensus sequence within this construct. The CRS potential of splice 
donor sequences has been demonstrated by the Rev-responsiveness of 
papillomavirus constructs containing a splice donor in the 3' untranslated 
region (Barksdale and Baker, 1995). The major 5' splice donor of equine 
infectious anemia virus functions as a CRS within EIA V Gag-producing 
constructs, although it functions in a location-dependent manner (Tan et 
al., 1996). Within HIV-l Env-expressing constructs, splice sites and Ul 
interaction have been shown to be important for the regulation of Env 
expression by Rev (Lu et al., 1990). Furthermore, the expression of Env 
could be made Rev-independent by placing a complete intron upstream of 
env and removing known splice donor sequences (Hammarskjold et al., 
1994). 
Other sequences within HIV-1, distinct from splice sites, have also 
been shown to exhibit CRS activity. Recently, a CRS has been identified 
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within HIV-l protease that functions in an orientation independent 
fashion to negatively regulate the cytoplasmic accumulation of Rev 
dependent RNA (Huffman and Arrigo, 1997). The fusion of various 
fragments of the gag, pol, and env genes to a CAT reporter construct 
resulted in Rev-responsiveness (Cochrane et al., 1991; Rosen et al., 1988). 
The CRS within pol elicited an orientation-dependent 30-fold negative 
effect on CAT activity that could be rescued by Rev and the RRE. This 
CRS is located within HIV-1 sequences that are not known to contain any 
splice sites. The effect appeared to be at the level of mRNA utilization, in 
that the subcellular distribution of RNA was not substantially affected. 
Other studies have shown that fusion of regions of both gag and pol to 
reporter constructs demonstrated at least two orientation-dependent CRS 
that functioned posttranscriptionally (Maldarelli, Martin, and Strebel, 
1991). These sequences do not contain known splice sites and were not 
substantially affected by the addition of splice sites to the constructs. 
Fusions of gag to a tat-expression vector were used to analyze CRS activity 
within gag (Schwartz, Felber, and Pavlakis, 1992a). Further research on 
gag sequences showed that a less than 300 base pair fragment was 
capable of exerting an effect on the total RNA production, which was 
attributed to differences in RNA stability. Mutational inactivation of this 
CRS required 28 point mutations, demonstrating the complex nature of 
this CRS (Schwartz et al., 1992). In the absence of known splice sites, env 
expression was shown to be Rev-dependent in mammalian cells using Env 
expression vectors (Nasioulas et al., 1994). Localization of CRS within env 
identified many regions capable of exerting modest negative activity, 
which together exerted more dramatic activity. Deletion of the RRE led to 
Rev-independent expression of Env from subgenomic env constructs, 
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indicating that a CRS may overlap RRE sequences (Brighty and 
Rosenberg, 1994; Churchill et al~, 1996). The complexity of the interaction 
between the gag CRS and splicing was recently demonstrated (Mikaelian 
et al., 1996). The gag CRS in conjunction with the RRE was capable of 
conferring Rev-responsiveness on a B-globin construct. Mutations in 
splice sites rendered these constructs Rev-independent. In summation, 
these studies indicate that there are several regions that contain CRS, 
which determine the viral requirement for Rev. 
A potential complication in the study of CRS and the Rev 
dependence of viral RNAs is the examination of these sequences in the 
context of other CRS. In order to determine the effect of a mutated splice 
donor in the context of other viral sequences, the major 5' splice donor was 
mutated in the context of gag sequences to determine the impact the 
mutation would have on the cytoplasmic accumulation of HIV-1 RNAs. 
The ratio of cytoplasmic to nuclear HIV-1 RNAs in the presence or absence 
of Rev was analyzed as an indicator of Rev dependence of the RNA. RT-
PCR was utilized to examine the localization of the RNAs produced by the 
transfected constructs. In this chapter, the effect of the major 5' splice 
donor, in the context of gag sequences, on the Rev-mediated regulation of 
HIV-1 RNAs was examined. 
Materials and Methods 
Plasmid Constructions 
The plasmids CSF and RoSt-A have been previously described (Campbell, 
Borg, and Arrigo, 1996; Favaro and Arrigo, 1997). Briefly, CSF is a wild 
type infectious proviral clone and RoST-A is a Rev mutant in which Rev is 
deleted through the introduction of a stop codon. RoST-A is also deleted for 
52 
a 3600bp pol fragment between the Avr II sites which renders the 
construct noninfectious. RoST-A ~SD1 was generated from the RoST-A 
construct using DR mutagenesis (Gatlin et al., 1995) and the following 
oligonucleotide primers: ~SD1 5'-
AGAACCGCGGACGCCGAAATTTTGACTAGCGGAGGC-3' and ~SD1A, 
5'-ACTACCGCGGGTCGCCGCCCCTCGCCTCTTGC-3'. This results in 
the deletion of the 5' major splice donor, TGGTGAGT from the RoST-A 
construct and the insertion of the sequence CCGCGG. 
Cell Culture and Transfection 
COS cells were maintained in Iscove's medium supplemented with 
10% fetal calf serum. Transfections were performed as described 
previously (Arrigo et al., 1989; Borg, Favaro, and Arrigo, 1997). A total of 
50 Jlg of plasmid DNA was electroporated for each sample. Cotransfections 
were performed with the indicated construct without or without the 
addition of 10Jlg pSVtat and/or 10Jlg pCMV Rev (Lewis et al., 1990). A filler 
construct (pcDNA3, Invitrogen) was used to normalize the total amount of 
DNA to 50Jlg. A confluent T175cm2 flask of cells was used for 
approximately six transfections. RNA was harvested approximately 18 
hours post-electroporation. 
RNA fractionation and analysis 
Cells were fractionated as previously described to obtain two 
cytoplasmic and a nuclear fraction (Borg, Favaro, and Arrigo, 1997; 
Favaro and Arrigo, 1997). Isolation of RNA and RT-PCR was performed as 
previously described (Arrigo and Chen, 1991; Arrigo et al., 1989; Arrigo et 
al~, 1990; Borg, Favaro, and Arrigo, 1997). RT-PCR was performed for 20 
cycles of amplification for all RNAs except that of the unspliced RNAs 
detected with the LA 8 / CSD2 and LA 8/ LA 9 oligonucleotides which 
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were amplified for 25 cycles. Most of the oligonucleotide primers used for 
detection have been previously described (Arrigo and Chen, 1991; Arrigo et 
al., 1989; Arrigo et al., 1990; Borg, Favaro, and Arrigo, 1997). Total RNA 
was detected with the LDR/aLDR oligonucleotides. Unspliced RNA was 
detected with several different pairs of oligonucleotides including LA 8 and 
LA 9, VPR-Xba and LA 23 and LA 8 and CSD2. The antisense 
oligonucleotide CSD2 hybridizes downstream of the identified cryptic 
splice donor and its sequence is 'CCCACCTATCCAATTCTC'. 
Quantitation of the ratio of cytoplasmic to nuclear RNA was done 
using a Molecular Dynamics phosphorimager. The cytoplasmic fractions 
(Cyto 1 and Cyto 2) were added together and compared to the nuclear 
fraction to determine the ratio of cytoplasmic to nuclear RNA. The level of 
nuclear RNA was arbitrarily set to a level of 1. 
Molecular Cloning and Sequencing of Cryptically Spliced RNA 
RT-PCR was performed as described above, on the first cytoplasmic 
fraction of RNA from the RoST-A ASDI transfection utilizing the 
LA8ILA23 oligonucleotides. This results in amplification of the spliced 
RNA. The resulting products were passed over a G50 column (Pharmacia). 
The DNA products were then ligated into the plasmid pGEM T-easy 
(Promega). The plasmids were then sequenced to determine the location of 
the cryptic splice donor. Sequencing of the plasmids was performed using 
an ABI 377 DNA sequencer for automated sequence analysis. Fluorescent 
dye-:labeled terminators were utilized in conjunction with the T7 primer to 
obtain the results. 
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Results 
Mutation of the 5' splice donor of HIV-l does not eliminate 
splicing to the downstream splice acceptor 
Previous studies have examined RNA expression following 
mutation of the major 5' splice donor of HIV-l and found that the splice 
site was responsible for Rev dependence when mutated in isolated splice 
donor containing constructs (Borg, Favaro, and Arrigo, 1997). One 
question raised by these experiments was how the 5' major splice donor 
might interact in the more natural context of the HIV-1 genome. In order 
to examine this question, the major 5' splice donor was mutated in the 
Rev-deleted construct RoSt-A to generate RoSt-A ASD1 (Figurel). This 
mutation deletes the consensus 'gt' required for splicing, as well as a 
previously identified cryptic splice donor immediately downstream 
(Purcell and Martin, 1993). These constructs are also deleted for pol; to 
render them noninfectious. The splice acceptors utilized to produce vif and 
vpr RNAs are deleted from these constructs. Transient transfections were 
performed in COS cells to assay for the cytoplasmic accumulation of HIV-l 
RNA. The RoSt-A and RoSt-A ASDI constructs were transfected in the 
presence of Tat and the presence or absence of Rev. A Tat-producing 
plasmid was cotransfected to provide a source of Tat for the transfections 
with the deletion of the 5' major splice donor. Since neither RoSt-A nor its 
derivative RoSt-A ASDI produces Rev, a Rev-producing plasmid or control 
plasmid was transfected to assess the effect of Rev on the cytoplasmic 
accumulation of RNA. After transfection, RNA was harvested from the 
cells after 18 hours and fractionated into three subcellular fractions. RNA 
was isolated and analyzed using quantitative RT-PCR procedure. 
A 
ILTRI gag vif tat vpu ILTRI r-,---..... c:::::::J _c env .. 
pro pol II 
I Drev • c:::::J 
LAB LA9 vpr nef 
~~ Vpr-Xba ~ ... gag/pol 
B 
T tmD CSF 
T • T RoSt-A 
T tmD T RoSt-AASDl 
Figure 3.1. Constructs and oligonucleotides used to identify and examine 
Rev regulation of a cryptic splice donor in HIV-l gene expression. 
Schematic diagram of HIV-l genome, HIV-l RNAs, and constructs 
generated. Section A depicts the viral genome with hypothetical RNAs 
produced via splicing. Oligonucleotide primers utilized for detection of 
various RNAs are depicted as arrows above the RNAs. LDR and aLDR are 
homologous to sequences in the RNA leader sequence present in all RNAs. 
LA8 is just upstream and LA9 is just downstream of the major 5' splice 
donor. CSD2 is just downstream of the cryptic splice donor. LA23 is just 
downstream of the 5' tat splice acceptor. Section B depicts the constructs 
(RoSt-A and RoSt-A ASD1) used in these experiments as compared to the 
wild type strain CSF. The major 5' HIV-l splice donor is represented as a 
filled triangle. Deletions are represented as open boxes. The filled circle 
represents the mutated splice donor site. The location of the RRE in the 
constructs is shown. The 'T' indicates the addition of a stop codon in RoSt-
A and RoSt-A ASDI that blocks Rev expression. 
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Examination of RNA expression utilizing oligonucleotides that 
detected all viral RNAs (LDR1/ aLDR1 on Figures 3.1 and 3.2A) indicated 
no change in distribution with the presence or absence of Rev or with 
mutation of the 5' major HIV-1 splice donor (see Figure 3.2A). The C:N 
ratios for the RNA examined with LDRI/ aLDRl were 2.2 and 1.9 for the 
RoSt-A (- and + Rev); and 1.6 and 2.5 for the RoSt-A ilSDl (- and + Rev) 
respectively. A ratio of 1:1 indicates that 50% of the RNA was found in the 
cytoplasmic fractions and 50% was found in the nuclear fraction. The 
decreased amount of RNA in the RoSt-A ilSDl plus Rev cytoplasmic 
fraction 2 was not reproducible. These results indicate that deletion of the 
splice donor resulted in little or no change in the total amount of HIV-l 
RNA produced by the constructs. 
Examination of RNA expression utilizing oligonucleotides that 
detect the unspliced RNA across the 5' HIV-1 splice donor (LA S/ LA9 on 
Figures 3.1 and 3.2A) revealed that the RoSt-A construct expressed 
cytoplasmic unspliced RNA in a Rev dependent manner. The addition of 
Rev was required for the cytoplasmic accumulation of unspliced RNA 
produced by the RoSt-A construct. However, the same RNA produced by 
the RoSt-A ilSD1 construct appeared Rev independent after mutation of 
the splice donor. The C:N ratios for the RNA examined with LAS/ LA 
9 were 0.2 and 1.9 for the RoSt-A (- and + Rev); and 1.1 and 1.4 for the 
RoSt-A ilSDl (- and + Rev) respectively. A small shift in the size of this 
unspliced RNA between the RoSt-A and RoSt-A ilSDl constructs was also 
observed. This is due to the loss of two bases with the splice site mutation. 
The unspliced RNA at this location was also analyzed utilizing another 
pair of oligonucleotides (LA Sand Gag- Nco) and yielded similar results; 
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respectively. These results indicated that the RNA produced by the RoSt-
A construct is dependent on Rev for its cytoplasmic accumulation and that 
the cytoplasmic accumulation of RNA produced by the RoSt-A dSDl 
construct is also dependent on the presence of Rev. Since total RNA 
(LDRI/ aLDRl) ratios are similar in the presence and absence of Rev, but 
the unspliced (Vpr-Xba and LA 23 and LA 8 and CSD2) are different with 
,respect to Rev-dependence; this indicates that splicing activity must be 
present in the RoSt-A dSDl construct. This cryptic splice donor must be 
located between LA 9 and LA 23. The utilization of this splice donor is also 
dependent on the presence of Rev. This is indicated by the fact that Rev 
increases the cytoplasmic accumulation of unspliced RNA containing the 
cryptic splice donor, while in the absence of Rev, cryptic splicing is 
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Figure 3.2. Identification of cryptic splicing and Rev dependence of RNAs 
in the presence and absence of Rev. Results of RT-PCR analysis, using 
different pairs of oligonucleotides, of fractionated RNAs (Cyto 1, Cyto 2 and 
Nuclear) from COS cells transfected with 30 Jlg of the indicated 
constructs. Cyto 1 and Cyto 2 fractions were generated using a buffer 
containing ,0.05% NP40 and 0.65% NP40, respectively. The remaining 
pellet was designated the Nuclear fraction. Threefold dilutions of RNA 
from transfected cells were assayed to demonstrate the quantitative 
nature of this procedure. All transfections also contained 10 Jlg of a Tat-
producing construct. The presence or absence of 10 Jlg of a Rev-producing 
construct is indicated (+ or -). Locations of the oligonucleotide pairs are 
listed in Figures 1 and 3. 
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Identification of a Cryptic Splice Donor 
The oligonucleotide primer set LA B and LA 23 were used to examine 
the pattern of spliced RNA and to attempt to identify the cryptic splice 
donor. These oligonucleotides will detect products that are spliced from 
the 5' major splice donor and downstream of that site to the tat splice 
acceptor (see Figure 3.1). Analysis of RNA with LA B and LA 23 indicated 
a Rev independent pattern of expression of the spliced RNA. The pattern of 
expression of RNA from both the RoSt-A and the RoSt-A i1SD1 constructs 
is similar in that neither is dependent on Rev for the cytoplasmic 
accumulation of RNA. The spliced RNA produced by the RoSt-A construct 
is primarily localized in the first cytoplasmic fraction and its cytoplasmic 
accumulation is largely unaffected by the presence or absence of Rev. The 
spliced RNA produced by the RoSt-A L1SDI construct is also primarily 
cytoplasmic in its distribution and not greatly affected by the 
cotransfection of a Rev producing plasmid. Interestingly, there may be a 
slight decrease in the level of cytoplasmic spliced RNA in the presence of 
Rev. There is a shift in size between the two species of RNA due to the 
different location of the splice donor. The cryptic splice donor is located 
further downstream of LAB resulting in a larger amplified product. 
The spliced RNA from the cytoplasmic 1 fraction of the RoSt-A L1SD1 
minus Rev transfection was amplified using the LA B and LA 23 primers 
(Figure 3.2B). Subsequently, these products were then cloned into the 
pGEM T-easy vector system for sequencing. The plasmids containing the 
cloned spliced RNA were then sequenced by an automated ABI 377 
sequencer. Sequencing of the cloned RNA with the T7 primer RNA yielded 
the location of a cryptic splice donor (Figure 3.3A). The sequencing 
identified the splice donor at 793bp in JRCSF as a 5/9 match to the 
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consensus sequence (Mount, 1982) This cryptic splice donor lies 
immediately downstream of the Gag ATG (Figure 3A). This cryptic splice 
donor was utilized with the tat splice acceptor at 5787 bp in JRCSF. The 
5/9 match for the identified cryptic site compares to the wild type 5' HIV-1 
splice donor which has 8/9 and the 3' major HIV-1 splice donor with 6/9 
match to the consensus for splice donors (Figure 3.3B). 
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Figure 3.3 Sequence ofHIV-1 at the 5' major splice donor and 
comparisons of cryptic splice sites. Section A of the figure depicts the DNA 
sequence ofHIV-1 JRCSF from 711 bp to 837 bp. The locations of the splice 
donors, oligonucleotides and Gag ATG are indicated. The Purcell splice 
donor indicates the cryptic splice donor noted by Purcell, et al. Section B of 
the figure depicts a comparison of the 5' major splice donor, the 3' major 
splice donor, a previously identified cryptic splice donor (Purcell and 
Martin, 1993), and the cryptic splice donor identified in this manuscript as 
compared to the consensus sequence. 
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Discussion 
The major 5' splice donor was analyzed, in the context of gag 
sequences, in order to determine its role on the Rev-mediated regulation of 
HIV-l RNAs. RNAs were analyzed by RT-PCR for cytoplasmic 
accumulation with different combinations of oligonucleotides utilized to 
assess the localization of different RNAs. The inactivation of the 5' major 
splice donor could yield one of three possible effects. First, all splicing 
could be eliminated from the RNA produced by the mutated construct. 
Second, all other (e.g. the 3' major splice donor) splicing events will 
remain but splicing in the 5' intronic region to the tat splice acceptor will 
be eliminated. The final possibility is that a cryptic splice donor would be 
activated in the 5' region and splicing will also occur in the 3' intronic 
region. The data presented in this chapter indicate that the third 
possibility is the most probable result of the inactivation of the 5' major 
splice donor. 
Using a pair of oligonucleotides that hybridize to a region common to 
all viral RNAs, total levels of HIV-l RNA were detected (LDRI/ aLDRl). A 
similar distribution of RNA was detected in the cellular fractions. Next, a 
pair of oligonucleotides that hybridize across the major splice donor was 
utilized to detect RNA that is unspliced at that location (LAB and LA 9). In 
the presence of the wild-type splice donor, this RNA was unspliced and 
required Rev for cytoplasmic accumulation. One caveat is that splicing 
may occur downstream of the sequences amplified, hence the PCR product 
detected is not necessarily entirely unspliced. When the 5' major splice 
donor was deleted in the RoSt-A ilSDl construct this RNA (LAB and LA 9) 
is largely independent of Rev for its cytoplasmic accumulation. With 
activation of a cryptic splice donor downstream, a shift of the 3' 
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oligonucleotide farther downstream (past the cryptic splice donor) again 
yields a PCR product that requires Rev for cytoplasmic accumulation (LA 
8 and CSD2). Therefore, a cryptic splice site or other CRS element is 
present downstream of LA 9. Oligonucleotide pairs were also used to 
examine the unspliced RNA across the tat splice acceptor (Vpr-Xba and LA 
23). These results when compared to the total RNA levels (LDR1/ aLDR1), 
which show equal levels of cytoplasmic accumulation, indicate that 
splicing is still occurring to this splice acceptor. The total ratios of RNA 
remained unchanged in the presence of Rev, while the unspliced RNA was 
dependent on Rev for cytoplasmic accumulation; therefore splicing must 
account for the rest of the total RNA. Analysis of the spliced RNA (LA 8 
and LA 23) indicated that the spliced products were independent of Rev 
and illustrated that a cryptic splice donor was splicing to the tat splice 
acceptor site. 
The sequence of this site was identified and compared to the 
consensus sequence. It is notable that such a poor match (5/9) to the 
consensus sequence was utilized as a splice site and regulated by Rev. 
However, it is only one basepair less of a match than the 3' major splice 
donor of HIV-l. A 5/9 match cryptic splice donor has also been reported 
previously in the literature (Purcell and Martin, 1993) (see Figure 3.3). 
Presence of this cryptic splice is especially interesting in light of the fact 
that there are a large number of possible cryptic sites when gag sequences 
were analyzed for consensus matches. Some of these sites are even better 
matches than this identified site. There are probably multiple cryptic 
sites activated upon mutation of the 5' major splice donor. However, no 
other cryptic splicing events were detected by RT-PCR analysis utilizing a 
large number of different oligonucleotide pairs throughout gag. 
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The fact that Rev regulation requires splice site recognition has 
been noted previously (Hammarskjold et al., 1994; Lu et al., 1990). Another 
study has reported that a cryptic splice donor is activated upon mutation 
of the wild-type splice donor (Purcell and Martin, 1993). The data 
presented here demonstrate activation of a cryptic splice donor with the 
inactivation of the 5' major splice donor and a previously identified cryptic 
splice donor. It was not unexpected that the unspliced RNA expressed 
from the RoSt-A ASD1 construct might remain Rev dependent due to the 
retention of numerous CRS that have been previously described (for 
review see Dayton) (Dayton, 1996) and that splicing might be present 
upon activation of cryptic splice donors. However, it is remarkable that 
the utilization of this splice donor would be dependent on Rev. In 
retrospect, this fact should not be surprising, as others have reported that 
suboptimal splice sites appear to be required for Rev regulation of splicing 
(Katz, 1990; O'Reilly, McNally, andBeemon, 1995). This is perhaps 
because splicing must be inefficient enough for Rev to differentially 
regulate the splicing process yet still able to have those sites interact with 
cellular splicing factors. The life history of HIV requires that it adapt to 
its ever changing genome. Consequently, the observation that a cryptic 
splice site immediately downstream of the Gag ATG is regulated by Rev 
further confirms the plastic nature of the HIV genome. These studies also 
present the possibility that cryptic splice donors may function as CRS in 






The question of how splice donors affect the cytoplasmic 
accumulation of HIV-l RNAs is part of a much larger discussion of how 
cells control the metabolism and expression of RNA. Many of the 
difficulties and problems in understanding HIV-l gene regulation result 
from our lack of molecular understanding of how cells intrinsically control 
these processes. Viruses provide an invaluable tool to probe the cellular 
machinery and yield remarkable insight about critical control points in 
the complex machinations of gene expression. The findings presented here 
add to the understanding of how viruses regulate RNA expression 
utilizing cellular processes to control their gene expression. 
The finding that an isolated splice donor functions as a CRS raises 
several questions. One is, whether splice donors function as a CRS 
through splicing or by binding a cellular factor and having an effect 
distinct from the splicing reaction. It is obvious that splicing decreases 
the amount of unspliced RNA in the cytoplasm. However, it is not clear 
that splice donors function as CRS merely through splicing of the RNA. 
Indeed the data presented in Chapter 2 support the interesting conclusion 
that an isolated splice donor in the presence of minimal splicing functions 
as a CRS. Ignoring for a moment the minimal splicing detected in these 
experiments, the findings show that a splice donor can function to 
negatively regulate the cytoplasmic accumulation of unspliced RNAs. The 
molecular event probably involves the binding of cellular factors such as 
VI which have been shown to be important in eRS function (Lu et al., 
1990). Binding of VI and other snRNPs must direct the RNA, in the 
absence of splicing to a degradative pathway. This must be true since the 
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RNA does not accumulate in the cytoplasm nor is it significantly spliced 
before transport from the nucleus. 
However, minimal splicing was detected in the isolated splice donor 
constructs and the possible mechanisms of this splicing are unclear with 
the removal of all known splice acceptor sequences and indeed almost all 
sequences downstream of the splice donor. Possible mechanisms for this 
might include trans or inverse splicing, rare but well described splicing 
events (Moore, Query, and Sharp, 1993). Alternatively, readthrough of the 
polyadenylation signal may be responsible for generating a larger RNA 
that would contain possible 3' cryptic splice acceptor sequences and allow 
for splicing. Indeed, readthrough of the polyadenyaltion signal in the 5' 
LTR occurs in HIV-1 gene expression, providing a precedent for this 
mechanism. In order to investigate these hypotheses we performed 3' 
rapid amplification of cDNA ends (RACE) to investigate the sequence of 
the spliced RNA but the results were inconclusive. 
Another interesting question raised by the findings in Chapter 2 is 
the difference in function between the two major splice donors of HIV-1. 
The ratios indicate that the second major splice donor is much less of a 
CRS than the 5' splice donor. It also is 3bp less of a match to the 
consensus sequence. It might seem probable that the degree of consensus 
sequence might function to determine the "strength" of a CRS. This might 
be true because an increase in binding of cellular factors to the CRS could 
increase the negative regulatory function of the CRS. The binding of 
splicing factors RNAs has been shown to retain RNAs in the nucleus 
(Stutz and Rosbash, 1994). It is important to remember that splicing must 
be regulated for the production of the different classes of viral RNA. In 
order for this regulation to occur, splicing of viral mRNA must be 
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inherently inefficient. If splice sites yield efficient splicing, then the 
reaction would be completed and it would be impossible to rescue unspliced 
RNA. The finding that an isolated splice donor can regulate the fate of an 
RNA, without splicing is novel and interesting. How does this relate back 
to wild-type viral expression? The next set of experiments was designed to 
investigate that question. 
Experiments in Chapter 3 address questions of splice donor function 
in the context of gag sequences. It is difficult to assess the impact of a 
particular CRS, such as the 5' major splice donor of HIV-l, in the context 
of other CRS. Mutation of one CRS does not eliminate negative regulation 
of the RNA because of the redundancy of these elements. These 
experiments identified a cryptic splice donor that is Rev-responsive. These 
findings raise several questions including- why do cryptic sites appear 
upon inactivation of wild-type sites? The answer is not readily apparent 
but several hypotheses are possible. One explanation for the presence of 
multiple cryptic sites is the presence of Rev. Since Rev is present during 
the expression of unspliced RNA to rescue the RNA there is no negative 
selection for the presence of cryptic elements. Indeed, with significant 
mutation rates in HIV-1 there maybe some selective pressure to maintain 
cryptic sequences so that the unspliced RNAs might remain Rev 
dependent even with a mutation of the wild-type splice donor. The reason 
for the redundancy of CRS function may never be known but it is curious 
to speculate on possible reasons for this feature of HIV-l gene regulation. 
Another interesting finding from Chapter 3 was the location of the 
cryptic splice donor that was identified. It is the next possible site 
downstream of the previous cryptic splice donor (Purcell and Martin, 
1993) which is immediately downstream of the wild type site. It is perhaps 
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significant that cryptic site selection appears to proceed 5' to 3' through 
the RNA. Also supporting this is the observation that several better 
possible cryptic sites exist in gag but do not appear to be utilized for 
cryptic splicing. 
These data suggest that all CRS might be splice sites or splice site-
binding elements. In support of this are the large number of possible 
cryptic sites that exist throughout HIV-1. Perhaps the intronic CRS 
discussed previously are merely sequences (or structures) that bind 
snRNPs and retain the unspliced RNA in the nucleus. Many of the 
identified CRS have been examined for splice sites and found to contain 
none but this does not rule out this mechanism of function. A consensus 
match may not be required for the binding of a particular factor that in 
association with a number of other proteins retain the unspliced RNAs in 
the nucleus. Such a mechanism would be extremely difficult to test, but 
might be a likely explanation of CRS function. 
One piece of evidence that might help evaluate this hypothesis is the 
finding of a CRS in protease that functions in an orientation independent 
manner and negatively regulated the cytoplasmic accumulation of RNA 
(Huffman and Arrigo, 1997). These sequences were examined for splicing 
events and none were detected. However, sequence analysis suggests that 
possible cryptic sites might exist. This may indicate that splicing was not 
present, but could also mean that snRNPs could still be bound to the RNA 
that retain the CRS containing RNA in the nucleus. Another note is that 
this sequence appears much weaker than the splice site CRS, which in 
addition to the orientation effect, is in support of a different mechanism of 
function. In light of this and other evidence it is difficult to assess the 
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nature of intronic CRS and whether they are cryptic splice sites or cryptic 














Figure 4.1 This is a hypothetical model of Rev function and its 
interaction with viral RNAs. The outside boundary is a cell membrane 
and the large oval structure represents the nucleus. The binding of Rev to 
various RNAs is depicted as are some of the feedback loops involved in Rev 
regulation of viral RNA expression. 
In light of these findings, a potential model of Rev function is shown 
in Figure 4.1. This figure shows the expression of Rev from the fully 
spliced RNA. This RNA is translated to produce Rev, which is localized to 
the nucleus via its NLS. Once in the nucleus Rev binds to the Rev 
response element located in Env. The binding of Rev then allows for 
rescue of the Rev-dependent RNA. Previous work has defined the role of 
the Rev response element (RRE) in HIV-1 gene regulation. The location of 
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the RRE has an important impact on RNA expression (Campbell, Borg, 
and Arrigo, 1996). 
The binding of Rev "rescues" the Rev-dependent unspliced and 
partially spliced RNAs for expression. Rev may also decrease its own 
expression while increasing the expression of Rev-dependent RNAs. 
Whether Rev actually decreases splicing, and thereby production of Rev, 
or whether Rev merely increases the export of the Rev dependent RNAs is 
uncertain. Popular belief holds that export explains the observed decrease 
in Rev expression but other data seems to suggest this may not be entirely 
true. Recent work has shown that Rev can function to inhibit splicing 
(Favaro and Arrigo, 1997). This work also showed that differences in cell 
type change the cellular requirement for Rev. While Cos cells absolutely 
require Rev for cytoplasmic accumulation of RNA, T cells have a low level 
of cytoplasmic accumulation in the absence of Rev (Arrigo and Chen, 1991; 
Favaro and Arrigo, 1997). Rev then facilitates the cytoplasmic 
accumulation of unspliced and partially spliced RNAs but also has further 
effects on the fate of the RNA. 
In the cytoplasm, Rev may also have critical effects on the 
regulation of RNA expression. Rev may have an important effect on 
translation of the Rev-dependent RNAs. This is supported by the 
observation that Rev is not absolutely required for cytoplasmic 
accumulation of Rev-dependent RNAs in the absence of Rev in lymphoid 
cells, whereas no expression of proteins occurs in the absence of Rev 
(Arrigo and Chen, 1991; Favaro and Arrigo, 1997). This level of control 
may involve association of the RNA with poly-A binding protein (PAB1). 
PABI binds to polyadenylated RNAs and facilitates 60s ribosomal subunit 
binding. In the absence of Rev, the Rev-dependent RNAs are defective in 
74 
their association with PAB1 (Campbell et al., 1994). This level of 
regulation may explain the lack of translation of these RNAs. 
Rev then has an impressive series of functions for a 19Kd protein. 
After binding to the RRE, Rev may function in splicing, export, stability 
and translation of the Rev-dependent RNAs as well as regulating its own 
production. How does Rev accomplish all of this? One theory is that Rev 
merely directs the RNA to different cellular pathways. By associating 
with a number of different cellular factors, it might influence the 
processing by the cellular machinery. In so doing, Rev appears to have 
many effects. This is especially true when you consider the many different 
systems used to analyze Rev function. As systems are different, the 
primary effect of Rev on the fate of the RNA may appear different. 
Interestingly, the ideas that were originally controversial are now 
becoming more accepted. The dominant export paradigm of Rev function is 
still questioned. This is not to say that Rev does not regulate export, 
merely that other effects are also critical functions of Rev in the regulation 
of RNA expression. 
In the regulation of gene expression, splice sites are critical features 
that direct RNA metabolism. HIV-1 utilizes the features of this processing 
to variably regulate the production of different RNAs from a single 
primary transcript. By using splice sites to control the expression of 
unspliced RNA, HIV-1 controls the temporal expression of the viral genes. 
The story of HIV-1 gene regulation is a complex tapestry of interwoven 
regulatory systems that not only provide important clues to 
understanding cellular gene expression but also contains the knowledge 
required to treat and prevent the Acquired Immune Deficiency Syndrome. 
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